MYC and plasma cell myeloma: However, a subset of genes also mapped to human chromosomes reportedly deleted in precursor myeloma patients (chr1p, chr2q, and chr13q)37, suggesting that these genes may mediate the pathogenic effects of chr5 loss in Vκ*MYC mice and in turn play a role in myeloma progression from precursor disease.